| Emma Claire Helman, | |
|
9850 W St Lukes Dr, Nampa, ID 83687-7912 | |
| (208) 205-7394 | |
| Not Available |
| Full Name | Emma Claire Helman |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 9850 W St Lukes Dr, Nampa, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205501723 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 03441065 (Ohio) | Secondary |
| 183500000X | Pharmacist | P9955 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emma Claire Helman, 750 S 5th W Apt D101, Mountain Home, ID 83647-4347 Ph: (330) 284-8740 | Emma Claire Helman, 9850 W St Lukes Dr, Nampa, ID 83687-7912 Ph: (208) 205-7394 |
News Archive
The Shareholders of Imagin Molecular Corporation ("IMGM") have approved, through a consent of over 51% of shareholder vote, certain transactions wherein IMGM completed the acquisition of 3,100,000 Class B Preferred Shares of Positron Corporation which shares are convertible on a 1 for 100 basis into Positron common shares.
The immune reaction at tumour site determines cancer evolution and clinical outcome in patients with colorectal cancer, regardless of the local extent and spread of the tumour, according to the findings of Jérôme Galon, INSERM Research Director, Paris, and co-workers.
Researchers at The Johns Hopkins University and other institutions report that a new laboratory test that induces cancer cells to squeeze through narrow spaces has the potential to accurately predict which breast cancers and other solid tumors are likely to spread, or metastasize, to other sites.
Intra-Cellular Therapies, Inc. ("ITI") and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive collaboration to develop and commercialize selective phosphodiesterase type 1 (PDE1) inhibitors, discovered by ITI, for the treatment of cognitive impairment associated with schizophrenia. This agreement is targeted worldwide, but ITI has retained the option to co-promote with Takeda in the United States.
Every hour, an enormous quantity and variety of manmade chemicals, having reached the end of their useful lifespan, flood into wastewater treatment plants. These large-scale processing facilities, however, are designed only to remove nutrients, turbidity and oxygen-depleting human waste, and not the multitude of chemicals put to residential, institutional, commercial and industrial use.
› Verified 5 days ago
Cheryl Driskell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16300 N Market Place Blvd, Nampa, ID 83687 Phone: 208-465-6801 | |
John A Anderson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 523 11th Ave N, Nampa, ID 83687 Phone: 208-466-2431 Fax: 208-466-2439 | |
Dustin Joseph Garcia, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2400 12th Ave Rd, Nampa, ID 83686 Phone: 208-465-6597 | |
Spencer A Graham, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2219 12th Ave Rd, Nampa, ID 83686 Phone: 208-318-0536 Fax: 208-318-0542 | |
Dr. Kelly Drollinger, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16300 N Market Place Blvd, Nampa, ID 83687 Phone: 208-465-6801 | |
Dr. Keith Bailey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16700 N Market Place Blvd, Nampa, ID 83687 Phone: 208-465-3809 | |
Mrs. Kathryn C Reynolds, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 12th Ave S, Nampa, ID 83651 Phone: 208-467-1560 Fax: 208-467-1823 |